Journal of neurotrauma, ISSN 0897-7151, 02/2019
The purpose of this review is to highlight the pharmacologic barrier to drug development for traumatic brain injury (TBI) and to discuss best practice...
Journal Article
Critical Care Medicine, ISSN 0090-3493, 09/2007, Volume 35, Issue 9, pp. 2196 - 2204
OBJECTIVES:Therapeutic hypothermia has been shown to decrease neurologic damage in patients experiencing out-of-hospital cardiac arrest. In addition to being...
Critical care | Drug metabolism | Pharmacokinetics | Cytochrome P450 | Hypothermia | critical care | CARDIOPULMONARY BYPASS | cytochrome P450 | HIGH-DOSE FENTANYL | MODERATE HYPOTHERMIA | CARDIAC-ARREST | TRAUMATIC BRAIN-INJURY | THERAPEUTIC HYPOTHERMIA | hypothermia | PLASMA FENTANYL CONCENTRATIONS | BILIARY-EXCRETION | drug metabolism | pharmacokinetics | MILD INTRAOPERATIVE HYPOTHERMIA | CORONARY-ARTERY SURGERY | CRITICAL CARE MEDICINE | Hypothermia, Induced - adverse effects | Pharmaceutical Preparations - metabolism | Chlorzoxazone - metabolism | Humans | Anesthetics - metabolism | Hypnotics and Sedatives - metabolism | Anticonvulsants - metabolism | Midazolam - metabolism | Cardiovascular Agents - metabolism | Neuromuscular Blocking Agents - metabolism | Cytochrome P-450 Enzyme System - physiology
Critical care | Drug metabolism | Pharmacokinetics | Cytochrome P450 | Hypothermia | critical care | CARDIOPULMONARY BYPASS | cytochrome P450 | HIGH-DOSE FENTANYL | MODERATE HYPOTHERMIA | CARDIAC-ARREST | TRAUMATIC BRAIN-INJURY | THERAPEUTIC HYPOTHERMIA | hypothermia | PLASMA FENTANYL CONCENTRATIONS | BILIARY-EXCRETION | drug metabolism | pharmacokinetics | MILD INTRAOPERATIVE HYPOTHERMIA | CORONARY-ARTERY SURGERY | CRITICAL CARE MEDICINE | Hypothermia, Induced - adverse effects | Pharmaceutical Preparations - metabolism | Chlorzoxazone - metabolism | Humans | Anesthetics - metabolism | Hypnotics and Sedatives - metabolism | Anticonvulsants - metabolism | Midazolam - metabolism | Cardiovascular Agents - metabolism | Neuromuscular Blocking Agents - metabolism | Cytochrome P-450 Enzyme System - physiology
Journal Article
PEDIATRIC CRITICAL CARE MEDICINE, ISSN 1529-7535, 01/2012, Volume 13, Issue 1, pp. 118 - 119
HYPOTHERMIA | HOSPITALIZED-PATIENTS | critical illness | ENZYMES | pediatrics | pharmacokinetics | midazolam, cytochrome P450 | MIDAZOLAM | UNITS | INTENSIVE-CARE | CRITICAL CARE MEDICINE | Humans | Critical Illness | Female | Male | Midazolam - pharmacokinetics | Multiple Organ Failure - drug therapy | Inflammation - physiopathology
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 09/2017, Volume 114, Issue 38, pp. E7997 - E8006
G protein-coupled receptors ( GPCRs) are classically characterized as cell-surface receptors transmitting extracellular signals into cells. Here we show that...
G protein-coupled receptor | Neuroprotection | Melatonin | Mitochondria | Ischemia | MUTANT | ACTIVATION | mitochondria | MULTIDISCIPLINARY SCIENCES | IDENTIFICATION | EXPERIMENTAL-MODELS | DAMAGE | ischemia | INTERLEUKIN-1-BETA CONVERTING-ENZYME | INHIBITION | neuroprotection | MOUSE MODEL | melatonin | RECEPTORS | CEREBRAL-ISCHEMIA | Signal Transduction | Cytochromes c - metabolism | Brain Ischemia - genetics | Brain Ischemia - metabolism | Male | Cytochromes c - genetics | Mitochondria - metabolism | Brain Injuries - genetics | Brain Injuries - metabolism | Receptor, Melatonin, MT1 - genetics | Animals | Mitochondria - genetics | Melatonin - biosynthesis | Mice | Melatonin - genetics | Receptor, Melatonin, MT1 - metabolism | Physiological aspects | G proteins | Biological Sciences | PNAS Plus
G protein-coupled receptor | Neuroprotection | Melatonin | Mitochondria | Ischemia | MUTANT | ACTIVATION | mitochondria | MULTIDISCIPLINARY SCIENCES | IDENTIFICATION | EXPERIMENTAL-MODELS | DAMAGE | ischemia | INTERLEUKIN-1-BETA CONVERTING-ENZYME | INHIBITION | neuroprotection | MOUSE MODEL | melatonin | RECEPTORS | CEREBRAL-ISCHEMIA | Signal Transduction | Cytochromes c - metabolism | Brain Ischemia - genetics | Brain Ischemia - metabolism | Male | Cytochromes c - genetics | Mitochondria - metabolism | Brain Injuries - genetics | Brain Injuries - metabolism | Receptor, Melatonin, MT1 - genetics | Animals | Mitochondria - genetics | Melatonin - biosynthesis | Mice | Melatonin - genetics | Receptor, Melatonin, MT1 - metabolism | Physiological aspects | G proteins | Biological Sciences | PNAS Plus
Journal Article
Nature Chemistry, ISSN 1755-4330, 2014, Volume 6, Issue 6, pp. 542 - 552
The central role of mitochondria in metabolic pathways and in cell-death mechanisms requires sophisticated signalling systems. Essential in this signalling...
CHEMICAL INHIBITION | PEROXIDASE-ACTIVITY | CARDIOLIPIN | TESTICULAR CYTOCHROME-C | INDUCED APOPTOSIS | BRAIN-INJURY | MASS-SPECTROMETRIC CHARACTERIZATION | OXIDATIVE LIPIDOMICS | LUNG INJURY | PHOSPHOLIPASE A | CHEMISTRY, MULTIDISCIPLINARY | Lysophospholipids - metabolism | Whole-Body Irradiation | Oxidants - pharmacology | Calcium - metabolism | Brain - metabolism | Group IV Phospholipases A2 - metabolism | Chromatography, Liquid | Female | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Intestine, Small - injuries | Oxidation-Reduction | Cytochromes c - metabolism | Mice, Inbred C57BL | Hydrogen Peroxide - pharmacology | Rats | Brain - radiation effects | Cardiolipins - metabolism | Mitochondria - metabolism | Fatty Acids, Unsaturated - metabolism | Mitochondria - drug effects | Cardiolipins - chemistry | Brain - drug effects | Animals | Intestine, Small - drug effects | Mice | Intestine, Small - metabolism
CHEMICAL INHIBITION | PEROXIDASE-ACTIVITY | CARDIOLIPIN | TESTICULAR CYTOCHROME-C | INDUCED APOPTOSIS | BRAIN-INJURY | MASS-SPECTROMETRIC CHARACTERIZATION | OXIDATIVE LIPIDOMICS | LUNG INJURY | PHOSPHOLIPASE A | CHEMISTRY, MULTIDISCIPLINARY | Lysophospholipids - metabolism | Whole-Body Irradiation | Oxidants - pharmacology | Calcium - metabolism | Brain - metabolism | Group IV Phospholipases A2 - metabolism | Chromatography, Liquid | Female | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Intestine, Small - injuries | Oxidation-Reduction | Cytochromes c - metabolism | Mice, Inbred C57BL | Hydrogen Peroxide - pharmacology | Rats | Brain - radiation effects | Cardiolipins - metabolism | Mitochondria - metabolism | Fatty Acids, Unsaturated - metabolism | Mitochondria - drug effects | Cardiolipins - chemistry | Brain - drug effects | Animals | Intestine, Small - drug effects | Mice | Intestine, Small - metabolism
Journal Article
Experimental Neurology, ISSN 0014-4886, 07/2019, Volume 317, pp. 10 - 21
Membrane transporters regulate the trafficking of endogenous and exogenous molecules across biological barriers and within the neurovascular unit. In traumatic...
ATP-binding cassette transporters | Traumatic brain injury | Neurovascular unit | Solute carriers | Blood-brain barrier | Multidrug resistance | Brain | Medical research | Drug resistance in microorganisms | Neurons | Medicine, Experimental | Amino acids | Single nucleotide polymorphisms | Glutamate | Injuries | Blood proteins
ATP-binding cassette transporters | Traumatic brain injury | Neurovascular unit | Solute carriers | Blood-brain barrier | Multidrug resistance | Brain | Medical research | Drug resistance in microorganisms | Neurons | Medicine, Experimental | Amino acids | Single nucleotide polymorphisms | Glutamate | Injuries | Blood proteins
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2014, Volume 9, Issue 10, p. e110162
Fatty liver disease is an emerging public health problem without effective therapies, and chronic hepatic inflammation is a key pathologic mediator in its...
SOLUBLE EPOXIDE HYDROLASE | HYDRODYNAMICS-BASED TRANSFECTION | MULTIDISCIPLINARY SCIENCES | MOUSE | ATHEROGENIC DIET | NONALCOHOLIC STEATOHEPATITIS | EICOSANOID METABOLISM | MICE | ARACHIDONIC-ACID | LARGE GENE LISTS | ENDOTHELIAL EXPRESSION | Biomarkers - metabolism | Fatty Liver - genetics | Epoxide Hydrolases - deficiency | Inflammation - pathology | Arachidonic Acid - metabolism | Liver - pathology | Liver - enzymology | Fatty Liver - blood | Fatty Liver - pathology | Mice, Inbred C57BL | Gene Expression Regulation | Cytochrome P-450 Enzyme System - metabolism | Hydrodynamics | Male | Inflammation - blood | Metabolic Networks and Pathways - genetics | Animals | Diet | Eicosanoids - metabolism | Lipids - blood | Atherosclerosis | Fatty Liver - enzymology | Inflammation - genetics | Epoxide Hydrolases - metabolism | Unsaturated fatty acids | Inflammation | Fatty liver | Analysis | Cytochrome P-450 | Cytochrome | Health sciences | Liver | Inflammatory response | Cardiovascular disease | Biosynthesis | Arachidonic acid | Phosphatase | Epoxide hydrolase | Biological effects | Atherogenic diet | Rodents | Hepatology | Drug therapy | Pharmaceutical sciences | Public health | Cardiovascular system | Enzymes | Liver diseases | Cytochrome P450 | Environmental health | Metabolism | Gene expression | Cholesterol | Biological activity | Nutrition research | Acids | Pharmacy | Mice | Laboratory animals | Apoptosis
SOLUBLE EPOXIDE HYDROLASE | HYDRODYNAMICS-BASED TRANSFECTION | MULTIDISCIPLINARY SCIENCES | MOUSE | ATHEROGENIC DIET | NONALCOHOLIC STEATOHEPATITIS | EICOSANOID METABOLISM | MICE | ARACHIDONIC-ACID | LARGE GENE LISTS | ENDOTHELIAL EXPRESSION | Biomarkers - metabolism | Fatty Liver - genetics | Epoxide Hydrolases - deficiency | Inflammation - pathology | Arachidonic Acid - metabolism | Liver - pathology | Liver - enzymology | Fatty Liver - blood | Fatty Liver - pathology | Mice, Inbred C57BL | Gene Expression Regulation | Cytochrome P-450 Enzyme System - metabolism | Hydrodynamics | Male | Inflammation - blood | Metabolic Networks and Pathways - genetics | Animals | Diet | Eicosanoids - metabolism | Lipids - blood | Atherosclerosis | Fatty Liver - enzymology | Inflammation - genetics | Epoxide Hydrolases - metabolism | Unsaturated fatty acids | Inflammation | Fatty liver | Analysis | Cytochrome P-450 | Cytochrome | Health sciences | Liver | Inflammatory response | Cardiovascular disease | Biosynthesis | Arachidonic acid | Phosphatase | Epoxide hydrolase | Biological effects | Atherogenic diet | Rodents | Hepatology | Drug therapy | Pharmaceutical sciences | Public health | Cardiovascular system | Enzymes | Liver diseases | Cytochrome P450 | Environmental health | Metabolism | Gene expression | Cholesterol | Biological activity | Nutrition research | Acids | Pharmacy | Mice | Laboratory animals | Apoptosis
Journal Article
Hypertension, ISSN 0194-911X, 09/2018, Volume 72, Issue Suppl_1
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2017, Volume 12, Issue 7, p. e0180280
There are no therapies shown to improve outcome after severe traumatic brain injury (TBI) in humans, a leading cause of morbidity and mortality. We sought to...
Intracranial Pressure - drug effects | Adjuvants, Pharmaceutic - pharmacology | Humans | Probenecid - blood | Child, Preschool | Acetylcysteine - cerebrospinal fluid | Male | Brain Injuries, Traumatic - cerebrospinal fluid | Glasgow Coma Scale | Intubation, Gastrointestinal | Female | Brain Injuries, Traumatic - blood | Probenecid - pharmacokinetics | Child | Brain Injuries, Traumatic - drug therapy | Double-Blind Method | Drug Administration Schedule | Probenecid - pharmacology | Glasgow Outcome Scale | Antioxidants - pharmacology | Biomarkers - blood | Body Temperature | Acetylcysteine - blood | Acetylcysteine - pharmacokinetics | Acetylcysteine - pharmacology | Adolescent | Survival Analysis | Adjuvants, Pharmaceutic - pharmacokinetics | Antioxidants - pharmacokinetics | Brain Injuries, Traumatic - mortality | Probenecid - cerebrospinal fluid | Brain | Usage | Clinical trials | Acetylcysteine | Children | Research | Health aspects | Injuries | Probenecid | Testing | Coma | Pediatrics | Drug delivery systems | Traumatic brain injury | Physicians | Critical care | Intracranial pressure | Cerebrospinal fluid | Epidemiology | Antioxidants | Randomization | Head injuries | Temperature effects | Rodents | Blood pressure | Pharmaceutical sciences | Antimicrobial agents | Patients | Morbidity | Medicine | Side effects | Brain research | Hospitals | Pharmacy | Biomarkers | Informed consent | Ventricle
Intracranial Pressure - drug effects | Adjuvants, Pharmaceutic - pharmacology | Humans | Probenecid - blood | Child, Preschool | Acetylcysteine - cerebrospinal fluid | Male | Brain Injuries, Traumatic - cerebrospinal fluid | Glasgow Coma Scale | Intubation, Gastrointestinal | Female | Brain Injuries, Traumatic - blood | Probenecid - pharmacokinetics | Child | Brain Injuries, Traumatic - drug therapy | Double-Blind Method | Drug Administration Schedule | Probenecid - pharmacology | Glasgow Outcome Scale | Antioxidants - pharmacology | Biomarkers - blood | Body Temperature | Acetylcysteine - blood | Acetylcysteine - pharmacokinetics | Acetylcysteine - pharmacology | Adolescent | Survival Analysis | Adjuvants, Pharmaceutic - pharmacokinetics | Antioxidants - pharmacokinetics | Brain Injuries, Traumatic - mortality | Probenecid - cerebrospinal fluid | Brain | Usage | Clinical trials | Acetylcysteine | Children | Research | Health aspects | Injuries | Probenecid | Testing | Coma | Pediatrics | Drug delivery systems | Traumatic brain injury | Physicians | Critical care | Intracranial pressure | Cerebrospinal fluid | Epidemiology | Antioxidants | Randomization | Head injuries | Temperature effects | Rodents | Blood pressure | Pharmaceutical sciences | Antimicrobial agents | Patients | Morbidity | Medicine | Side effects | Brain research | Hospitals | Pharmacy | Biomarkers | Informed consent | Ventricle
Journal Article
Pediatric Research, ISSN 0031-3998, 07/2017, Volume 82, Issue 1, pp. 29 - 35
BACKGROUND: The gene ABCB1 encodes p-glycoprotein, a xenobiotic efflux pump capable of transporting certain opioids, including fentanyl. ABCB1 genotype has...
PEDIATRIC INTENSIVE-CARE | PAIN | MANAGEMENT | TRAUMATIC BRAIN-INJURY | SEDATION | PEDIATRICS | P-GLYCOPROTEIN EXPRESSION | GENE POLYMORPHISMS | WITHDRAWAL | DEPENDENCE | ANALGESIA | Genotype & phenotype | Pediatrics | Drug delivery systems | Glycoproteins
PEDIATRIC INTENSIVE-CARE | PAIN | MANAGEMENT | TRAUMATIC BRAIN-INJURY | SEDATION | PEDIATRICS | P-GLYCOPROTEIN EXPRESSION | GENE POLYMORPHISMS | WITHDRAWAL | DEPENDENCE | ANALGESIA | Genotype & phenotype | Pediatrics | Drug delivery systems | Glycoproteins
Journal Article
Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 07/2011, Volume 7, Issue 7, pp. 803 - 816
Introduction: Therapeutic hypothermia is being employed clinically due to its neuro-protective benefits. Both critical illness and therapeutic hypothermia...
drug response | critical care | pharmacokinetics | therapeutic hypothermia | drug metabolism | BIOCHEMISTRY & MOLECULAR BIOLOGY | MILD HYPOTHERMIA | PHARMACODYNAMICS | MODERATE HYPOTHERMIA | GENTAMICIN | ENCEPHALOPATHY | ANESTHESIA | IMPACT | BIOTRANSFORMATION | CARDIAC-ARREST | PHARMACOLOGY & PHARMACY | TOXICOLOGY | Dose-Response Relationship, Drug | Inactivation, Metabolic | Animals | Humans | Hypothermia, Induced | Body Temperature | Aryl Hydrocarbon Hydroxylases - metabolism
drug response | critical care | pharmacokinetics | therapeutic hypothermia | drug metabolism | BIOCHEMISTRY & MOLECULAR BIOLOGY | MILD HYPOTHERMIA | PHARMACODYNAMICS | MODERATE HYPOTHERMIA | GENTAMICIN | ENCEPHALOPATHY | ANESTHESIA | IMPACT | BIOTRANSFORMATION | CARDIAC-ARREST | PHARMACOLOGY & PHARMACY | TOXICOLOGY | Dose-Response Relationship, Drug | Inactivation, Metabolic | Animals | Humans | Hypothermia, Induced | Body Temperature | Aryl Hydrocarbon Hydroxylases - metabolism
Journal Article
Journal of Neurotrauma, ISSN 0897-7151, 03/2016, Volume 33, Issue 6, pp. 581 - 594
Levetiracetam (LEV) is an antiepileptic agent targeting novel pathways. Coupled with a favorable safety profile and increasing empirical clinical use, it was...
Original Articles | controlled cortical impact | rat | post-traumatic seizures | Keppra | neuroprotection | therapy | penetrating ballistic-like brain injury | fluid percussion | biomarker | excitotoxicity | HYPOTHERMIA | PROTEIN | SEIZURE PROPHYLAXIS | POSTTRAUMATIC EPILEPSY | STATUS EPILEPTICUS | MODEL | NEUROSCIENCES | CLINICAL NEUROLOGY | INTRAVENOUS LEVETIRACETAM | DEFICITS | CRITICAL CARE MEDICINE | Recovery of Function - drug effects | Rats | Male | Biomarkers - blood | Brain Injuries, Traumatic | Rats, Sprague-Dawley | Ubiquitin Thiolesterase - blood | Glial Fibrillary Acidic Protein - blood | Animals | Piracetam - analogs & derivatives | Piracetam - pharmacology | Nootropic Agents - pharmacology | Disease Models, Animal | Brain | Care and treatment | Dosage and administration | Research | Biological markers | Injuries | Levetiracetam | Brain damage | Drug therapy | Clinical outcomes | Neurobiology
Original Articles | controlled cortical impact | rat | post-traumatic seizures | Keppra | neuroprotection | therapy | penetrating ballistic-like brain injury | fluid percussion | biomarker | excitotoxicity | HYPOTHERMIA | PROTEIN | SEIZURE PROPHYLAXIS | POSTTRAUMATIC EPILEPSY | STATUS EPILEPTICUS | MODEL | NEUROSCIENCES | CLINICAL NEUROLOGY | INTRAVENOUS LEVETIRACETAM | DEFICITS | CRITICAL CARE MEDICINE | Recovery of Function - drug effects | Rats | Male | Biomarkers - blood | Brain Injuries, Traumatic | Rats, Sprague-Dawley | Ubiquitin Thiolesterase - blood | Glial Fibrillary Acidic Protein - blood | Animals | Piracetam - analogs & derivatives | Piracetam - pharmacology | Nootropic Agents - pharmacology | Disease Models, Animal | Brain | Care and treatment | Dosage and administration | Research | Biological markers | Injuries | Levetiracetam | Brain damage | Drug therapy | Clinical outcomes | Neurobiology
Journal Article
Journal of Neurotrauma, ISSN 0897-7151, 03/2016, Volume 33, Issue 6, pp. 66 - 614
Operation Brain Trauma Therapy (OBTT) is a fully operational, rigorous, and productive multicenter, pre-clinical drug and circulating biomarker screening...
Original Articles | pre-clinical modeling | controlled cortical impact | micropig | rat | reproducibility | therapy | penetrating ballistic-like brain injury | traumatic brain injury | fluid percussion | biomarker | drug | MICROGLIAL ACTIVATION | PERFORMANCE | INJURY | NEUROSCIENCES | RAT MODEL | NEUROPROTECTION | CLINICAL NEUROLOGY | HEMORRHAGIC-SHOCK | AMANTADINE | MICE | DEFICITS | CRITICAL CARE MEDICINE | Neuroprotective Agents - therapeutic use | Drug Evaluation, Preclinical - methods | Neurology - trends | Animals | Brain Injuries, Traumatic - drug therapy | Drug Evaluation, Preclinical - trends | Rats | Male | Neurology - methods | Rats, Sprague-Dawley | Disease Models, Animal | Brain | Usage | Care and treatment | Clinical trials | Research | Biological markers | Injuries | Biomarkers | Brain damage | Drug therapy | Neurobiology
Original Articles | pre-clinical modeling | controlled cortical impact | micropig | rat | reproducibility | therapy | penetrating ballistic-like brain injury | traumatic brain injury | fluid percussion | biomarker | drug | MICROGLIAL ACTIVATION | PERFORMANCE | INJURY | NEUROSCIENCES | RAT MODEL | NEUROPROTECTION | CLINICAL NEUROLOGY | HEMORRHAGIC-SHOCK | AMANTADINE | MICE | DEFICITS | CRITICAL CARE MEDICINE | Neuroprotective Agents - therapeutic use | Drug Evaluation, Preclinical - methods | Neurology - trends | Animals | Brain Injuries, Traumatic - drug therapy | Drug Evaluation, Preclinical - trends | Rats | Male | Neurology - methods | Rats, Sprague-Dawley | Disease Models, Animal | Brain | Usage | Care and treatment | Clinical trials | Research | Biological markers | Injuries | Biomarkers | Brain damage | Drug therapy | Neurobiology
Journal Article
Drug Metabolism and Disposition, ISSN 0090-9556, 01/2011, Volume 39, Issue 1, pp. 22 - 29
Cytochrome P450 (P450)-mediated metabolism of arachidonic acid regulates inflammation in hepatic and extrahepatic tissue. CYP2C/CYP2J-derived...
RAT-LIVER | SOLUBLE EPOXIDE HYDROLASE | INHIBITION | CLONING | ENZYMES | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | ARACHIDONIC-ACID | MODEL | SUPPRESSION | MODULATION | Tumor Necrosis Factor-alpha - metabolism | Microsomes - metabolism | Microsomes, Liver - metabolism | Arachidonic Acid - blood | Cytochrome P-450 Enzyme System - metabolism | Male | Lipopolysaccharides - immunology | Microsomes - drug effects | Tandem Mass Spectrometry | Inflammation - metabolism | Kidney - metabolism | Time Factors | Lung - metabolism | RNA - metabolism | Kidney - drug effects | Mice, Inbred C57BL | Immunity, Innate | Animals | Eicosanoids - metabolism | Lung - drug effects | Cytochrome P-450 Enzyme System - biosynthesis | Cytochrome P-450 Enzyme System - genetics | Heart - drug effects | Mice | Tumor Necrosis Factor-alpha - biosynthesis
RAT-LIVER | SOLUBLE EPOXIDE HYDROLASE | INHIBITION | CLONING | ENZYMES | GENE-EXPRESSION | PHARMACOLOGY & PHARMACY | ARACHIDONIC-ACID | MODEL | SUPPRESSION | MODULATION | Tumor Necrosis Factor-alpha - metabolism | Microsomes - metabolism | Microsomes, Liver - metabolism | Arachidonic Acid - blood | Cytochrome P-450 Enzyme System - metabolism | Male | Lipopolysaccharides - immunology | Microsomes - drug effects | Tandem Mass Spectrometry | Inflammation - metabolism | Kidney - metabolism | Time Factors | Lung - metabolism | RNA - metabolism | Kidney - drug effects | Mice, Inbred C57BL | Immunity, Innate | Animals | Eicosanoids - metabolism | Lung - drug effects | Cytochrome P-450 Enzyme System - biosynthesis | Cytochrome P-450 Enzyme System - genetics | Heart - drug effects | Mice | Tumor Necrosis Factor-alpha - biosynthesis
Journal Article